← Eichor
Study identifier: NCT07200115 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

RCT of Cervical Ripening Double Ballon Catheter Prior to Dilation and Evacuation.

Condition: Cervical Preparation Prior to Dilation and Evacuation  ·  Sponsor: Yale University

PhaseNA
Planned participants50
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to determine whether the overnight use of an FDA-cleared CRDB catheter is superior to the use of overnight osmotic dilators as is standard of care cervical preparation for patients presenting for dilation and evacuation (D\&E). The CRDB catheter is an FDA cleared device for cervical dilation prior to labor induction at term. It has not been FDA cleared for cervical dilation in the second-trimester, however, will be used in a similar fashion to labor inductions at term. Our standard of care osmotic dilators (e.g., laminaria, Dilapan-S) are both FDA cleared for cervical dilation prior to labor induction at term or gynecologic procedures requiring cervical dilation.

This description comes directly from the study's public registry record.

Talk to the study team

Yale Family Planning  ·  203-785-5074  ·  fpresearch@yale.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Yale Family Planning ClinicNew Haven, Connecticut, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07200115